de Ruiter JC - Search Results

1

Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.

de Ruiter JC, van Diessen JNA, Smit EF, van der Noort V, Damhuis RAM, Hartemink KJ; ESLUNG group. de Ruiter JC, et al. Eur J Cardiothorac Surg. 2022 Aug 3;62(3):ezac118. doi: 10.1093/ejcts/ezac118. Eur J Cardiothorac Surg. 2022. PMID: 35348664

2

The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.

de Ruiter JC, Heineman DJ, Daniels JM, van Diessen JN, Damhuis RA, Hartemink KJ. de Ruiter JC, et al. Lung Cancer. 2020 Jun;144:64-70. doi: 10.1016/j.lungcan.2020.04.005. Epub 2020 Apr 19. Lung Cancer. 2020. PMID: 32371262

3

Stage I non-small cell lung cancer: Treatment modalities, Dutch daily practice and future perspectives.

Hopstaken JS, de Ruiter JC, Damhuis RAM, de Langen AJ, van Diessen JNA, Klomp HM, Klompenhouwer EG, Hartemink KJ. Hopstaken JS, et al. Among authors: de ruiter jc. Cancer Treat Res Commun. 2021;28:100404. doi: 10.1016/j.ctarc.2021.100404. Epub 2021 May 21. Cancer Treat Res Commun. 2021. PMID: 34058517 Free article. Review.

4

Centralization of lung cancer surgery in the Netherlands: differences in care and survival of patients with stage I non-small cell lung cancer between hospitals with and without in-house lung cancer surgery.

de Ruiter JC, Heineman DJ, de Langen AJ, Dahele M, Damhuis RAM, Hartemink KJ. de Ruiter JC, et al. Acta Oncol. 2020 Apr;59(4):384-387. doi: 10.1080/0284186X.2019.1711168. Epub 2020 Jan 7. Acta Oncol. 2020. PMID: 31910699 No abstract available.

5

Reply to Peng et al.

de Ruiter JC, Smit EF, van der Noort V, Hartemink KJ. de Ruiter JC, et al. Eur J Cardiothorac Surg. 2022 Jun 15;62(1):ezac310. doi: 10.1093/ejcts/ezac310. Eur J Cardiothorac Surg. 2022. PMID: 35640126 No abstract available.

6

[Treatment of non-small cell lung cancer].

Hopstaken JS, de Ruiter JC, van Diessen JNA, Theelen WSME, Monkhorst K, Hartemink KJ. Hopstaken JS, et al. Among authors: de ruiter jc. Ned Tijdschr Geneeskd. 2021 Feb 4;165:D5486. Ned Tijdschr Geneeskd. 2021. PMID: 33651512 Review. Dutch.

7

Model studies in adjuvant chemotherapy.

Mulder JH, de Ruiter J, Edelstein MB, Gerritsen TF, van Putten LM. Mulder JH, et al. Cancer Treat Rep. 1983 Jan;67(1):45-50. Cancer Treat Rep. 1983. PMID: 6616492

8

Adjuvant chemotherapy: theoretical considerations and model studies.

van Putten LM, de Ruiter J, van de Velde CJ, Mulder JH, Gerritsen AF. van Putten LM, et al. Recent Results Cancer Res. 1979;67:119-25. doi: 10.1007/978-3-642-81320-7_18. Recent Results Cancer Res. 1979. PMID: 451320

9

Studies on the enhancement by cyclophosphamide (NSC-26271) of artificial lung metastasis after labeled cell inoculation.

de Ruiter J, Smink T, van Putten LM. de Ruiter J, et al. Cancer Treat Rep. 1976 Apr;60(4):465-70. Cancer Treat Rep. 1976. PMID: 1064469

10

The facilitation of tumour growth in the lung by cyclophosphamide in artificial and spontaneous metastases models.

de Ruiter J, Cramer SJ, Smink T, van Putten LM. de Ruiter J, et al. Eur J Cancer (1965). 1979 Sep;15(9):1139-49. doi: 10.1016/0014-2964(79)90130-0. Eur J Cancer (1965). 1979. PMID: 527634 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page